4SC AG
4SC presents Phase I data on its histone deacetylase HDAC inhibitor 4SC-201 at ASCO
Published in Hospital Business Week, June 14th, 2009
4SC AG (Frankfurt, Prime Standard: VSC) the German drug discovery and development company, in conjunction with Royal Marsden Hospital in Sutton, England, announced that it will present Phase I data on 4SC-201, an innovative histone deacetylase (HDAC) inhibitor, at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, USA, from May 29 to June 2, 2009. The Phase I data, generated in advanced solid tumors will form the basis of 4SC's drug development program in oncology.
In the Phase I trial, 4SC 201 was orally administered to 18 patients and was applied in therapy cycles, consisting of a once daily oral dose over five consecutive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- ACS
ACS Develops E-prescribing Capability for Alabama Medicaid - Affymax, Inc.
Affymax® Reports Phase 2 Clinical Trial Data Supporting Hemoglobin Increases with Once-Per-Month Hematide™ Regardless of Patient Baseline Renal Function - Allscripts
Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record - Alpha Systems
Alpha Systems Best in KLAS - American Jewish Committee
AJC: Libya is Responsible for Death of Human Rights Activist - Ballast Nedam Nv
Erasmus MC Awards Major Hospital Contract to BAM-Ballast Nedam Joint Venture - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
